Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from Owens & Minor ( (OMI) ) is now available.
On February 3, 2025, Owens & Minor, Inc. announced preliminary financial results for the fourth quarter and full year 2024 ahead of its scheduled earnings announcement. The company is initiating financing to support its acquisition of Rotech Healthcare Holdings, Inc., leveraging the current favorable capital market conditions. Despite a challenging year marked by a non-cash goodwill impairment charge of approximately $310 million, attributed to financial market changes and contract pricing adjustments, the company reported healthy growth in its Patient Direct segment and reduced total debt by over $240 million.
More about Owens & Minor
Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company offering essential products and services that support care from hospitals to homes. The company, along with its affiliated brands Apria, Byram, and HALYARD, has been serving patients, providers, and communities for over 100 years, supported by a workforce of more than 20,000 employees worldwide.
YTD Price Performance: 10.82%
Average Trading Volume: 616,390
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.1B
For a thorough assessment of OMI stock, go to TipRanks’ Stock Analysis page.
